BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been included in the "Commercial Insurance Innovative Drug List", recently introduced by ...
In high school health class, way back in 1989, we learned that a beer, a properly measured shot of liquor, and a glass of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback